Personalis, Inc. Income Tax Examination, Penalties and Interest Expense
Personalis, Inc. (PSNL) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Interest Expense
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2026-02-26
- Personalis, Inc. income tax examination, penalties and interest expense for fiscal 2025 was $0.00.
- Personalis, Inc. income tax examination, penalties and interest expense for fiscal 2024 was $0.00.
- Personalis, Inc. income tax examination, penalties and interest expense for fiscal 2023 was $0.00.
- Personalis, Inc. income tax examination, penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |